Hospitalizations for heart failure in the United States - A sign of hope

JAMA

Volumn 306, Issue 15, 2011, Pages 1705-1706

  Gheorghiade, Mihai ^a   Braunwald, Eugene ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN;

AFRICAN AMERICAN; CAUCASIAN; COMORBIDITY; CORONARY ARTERY DISEASE; EDITORIAL; HEALTH SERVICE; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; POSTDISCHARGE VISIT; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

EID: 80054749733     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1510     Document Type: Editorial

References (20)

1. Pang PS, Komajda M, Gheorghiade M. The current and future management of acute heart failure syndromes. Eur Heart J. 2010;31(7):784-793.
2. Cuffe MS, Califf RM, Adams KF Jr, et al. Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287(12):1541- 1547. (Pubitemid 34269999)
3. Gheorghiade M, Abraham WT, Albert NM, et al. OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296(18): 2217-2226. (Pubitemid 44708052)
4. Bueno H, Ross JS, Wang Y, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA. 2010;303(21):2141-2147.
5. Bonow RO, Bennett S, Casey DE Jr, et al. ACC/AHA clinical performance measures for adults with chronic heart failure. Circulation. 2005;112(12):1853-1887.
6. Fonarow GC, Abraham WT, Albert NM, et al. OPTIMIZE-HF Investigators and Hospitals. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297(1):61-70. (Pubitemid 46041727)
7. Chen J, Normand S-LT, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA. 2011;306(15):1669-1678.
8. O'Connor CM, Miller AB, Blair JE, et al.; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) investigators. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. Am Heart J. 2010;159(5):841-849.
9. Ahmed A, Rich MW, Fleg JL, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure. Circulation. 2006;114(5):397-403.
10. Lee DS, Schull MJ, Alter DA, et al. Early deaths in patients with heart failure discharged from the emergency department. Circ Heart Fail. 2010;3(2):228-235.
11. Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006; 119(12)(suppl 1):S3-S10. (Pubitemid 44755377)
12. Pang PS, Gheorghiade M, Dihu J, et al. Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes. Am Heart J. 2011;161(6):1067-1072.
13. Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure. Eur J Heart Fail. 2010;12(5):423-433.
14. Felker GM, Lee KL, Bull DA, et al. NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364(9):797-805.
15. Gheorghiade M, Peterson ED. Improving postdischarge outcomes in patients hospitalized for acute heart failure syndromes. JAMA. 2011;305(23):2456-2457.
16. Shah SJ, Gheorghiade M. Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA. 2008;300(4):431-433. (Pubitemid 352040255)
17. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336(8):525-533.
18. Zannad F, McMurray JJ, Krum H, et al. EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011; 364(1):11-21.
19. Gheorghiade M, Pang PS, Ambrosy AP, et al. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days [published online September 20, 2011]. Heart Fail Rev. doi:10.1007 /s10741-011-9280-0.
20. Metra M, Gheorghiade M, Bonow RO, Dei Cas L. Postdischarge assessment after a heart failure hospitalization. Circulation. 2010;122(18):1782-1785.